AMGEN INC (AMGN): SEC Filings & AI Analysis

Health Care. Latest 10-K, 10-Q, and 8-K filings for AMGEN INC (AMGN) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.

Most recent filing — 10-Q filed August 5, 2026: NEUTRAL Concern level: ELEVATED.

Company overview — key questions

Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.

What is AMGEN INC (AMGN)?

AMGEN INC is a publicly traded company in the Health Care space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.

What are AMGN's most recent SEC filings?

Recent filings: 10-Q (August 5, 2026), 8-K (August 4, 2026), 8-K (July 31, 2026), 8-K (May 20, 2026), 8-K (May 19, 2026).

What does AMGN's latest filing analysis show?

AMGN's most recent 10-Q (August 5, 2026) is rated NEUTRAL, concern level ELEVATED.

What is the 30-day outlook for AMGN?

Based on AMGN's latest filing, the model projects it will perform roughly in line with the S&P 500 over the next 30 days. This is model analysis for research, not investment advice.

Is AMGN a buy?

StockHuntr doesn't issue buy or sell ratings — it's a research tool. For AMGEN INC (AMGN), its latest 10-Q is rated ELEVATED concern and the model projects it will perform roughly in line with the S&P 500 over 30 days. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.

Recent AMGN filings analyzed

  • 10-Q · Aug 5, 2026 · concern 4.2/10
  • 8-K · Aug 4, 2026 · concern 1.2/10
  • 8-K · Jul 31, 2026 · concern 7.2/10

Compare across the sector: Health Care sector analysis →

Other Health Care companies

About this analysis

Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
August 5, 2026
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

Loading AMGN snapshot...

Fetching live market data